225 filings
8-K
BKYI
Bio-Key International Inc.
2 Apr 24
Operating Loss Trimmed Approx. $3.5M on Approx. 29% Revenue Growth to $9.1M; Investor Call Tomorrow at 10am ET
8:30am
8-K
BKYI
Bio-Key International Inc.
11 Jan 24
Other Events
11:54am
8-K
BKYI
Bio-Key International Inc.
21 Dec 23
Entry into a Material Definitive Agreement
4:46pm
8-K
BKYI
Bio-Key International Inc.
19 Dec 23
Following Stockholder Approval, BIO-key Announces 1-for-18 Reverse Stock Split
8:30am
8-K
BKYI
Bio-Key International Inc.
13 Nov 23
Departure of Directors or Certain Officers
4:45pm
8-K
e35ls0e6
2 Nov 23
BIO-key International Announces Pricing of $3.75 Million Public Offering
10:38am
8-K
sftt9kqf6t5jjhi1l0
25 Oct 23
Results of Operations and Financial Condition
1:19pm
8-K
0m8zeg4gqb6og
15 Aug 23
Results of Operations and Financial Condition
8:15am
8-K
clafmgvj
26 Jul 23
Submission of Matters to a Vote of Security Holders
4:45pm
8-K
psevgy46e 0zvp32duf
14 Jul 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:42pm
8-K
e0cmpr vo
27 Jun 23
Entry into a Material Definitive Agreement
4:45pm
8-K
kd7ima6ed4hd
13 Jun 23
Other Events
5:48pm
8-K
w6lvy qi1
2 Jun 23
Departure of Directors or Certain Officers
4:31pm
8-K
dy5sv
30 May 23
BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq
4:45pm
8-K
a069gjxp8 gdef8p
16 May 23
Results of Operations and Financial Condition
8:30am
8-K
ygxm7x0j6 eo3rhbjlz
24 Apr 23
BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq
4:40pm
8-K
6z5hsvvl
20 Apr 23
Departure of Directors or Certain Officers
4:30pm
8-K
9aoosd6fa1z
31 Mar 23
Expects record quarterly revenue in Q1 2023
8:30am
8-K
p8bre8 6v
15 Feb 23
Departure of Directors or Certain Officers
5:00pm
8-K
5hxo6tw09m5awowq
13 Jan 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:04pm